Working... Menu
Trial record 36 of 402 for:    bleeding episodes

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03407651
Recruitment Status : Completed
First Posted : January 23, 2018
Last Update Posted : May 24, 2019
Information provided by (Responsible Party):
Catalyst Biosciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 15, 2019
  Actual Study Completion Date : April 13, 2019